Visium Asset Management’s Biogen BIIB Stock Holding History

Visium Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-381,642	Closed	-$99.3M	–	364
2016 Q1	$99.3M	Buy	+381,642	New	+$101M	1.69%	6
2015 Q4	–	Sell	-222,802	Closed	-$65M	–	606
2015 Q3	$65M	Buy	222,802 +220,092	+8,121%	+$72.7M	0.89%	20
2015 Q2	$1.09M	Sell	2,710 -2,219	-45%	-$891K	0.02%	508
2015 Q1	$2.08M	Sell	4,929 -786	-14%	-$310K	0.03%	420
2014 Q4	$1.94M	Buy	+5,715	New	+$1.85M	0.03%	423
2014 Q1	–	Sell	-4,400	Closed	-$1.23M	–	876
2013 Q4	$1.23M	Buy	4,400 +780	+22%	+$202K	0.02%	421
2013 Q3	$872K	Buy	3,620 +2,652	+274%	+$594K	0.02%	450
2013 Q2	$209K	Buy	+968	New	+$207K	﹤0.01%	635

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Visium Asset Management's BIIB Position: Q2 2016 in Review

Visium Asset Management sold out of Biogen (BIIB) in Q2 2016, closing a stake of 381,642 shares — an estimated $99.3M sold.

Visium Asset Management first reported a position in BIIB in Q2 2013 and held it in 8 quarters. The position peaked at $99.3M in Q1 2016. 966 funds tracked by Wall St. Rank hold BIIB as of Q2 2016.

Visium Asset Management reported no remaining Biogen position as of Q2 2016 after selling out during the quarter.
Visium Asset Management sold 381,642 Biogen shares in Q2 2016, an estimated $99.3M.
Visium Asset Management first reported a position in Biogen in Q2 2013 and held it in 8 quarters.
Visium Asset Management's Biogen position peaked at $99.3M in Q1 2016.
966 funds tracked by Wall St. Rank held Biogen as of Q2 2016.

Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.